Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 1
2009 1
2011 3
2012 3
2013 4
2014 6
2015 3
2016 3
2017 3
2018 3
2019 2
2020 3
2021 2
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

38 results
Results by year
Filters applied: . Clear all
Page 1
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L; ASCLEPIOS I and ASCLEPIOS II Trial Groups. Hauser SL, et al. N Engl J Med. 2020 Aug 6;383(6):546-557. doi: 10.1056/NEJMoa1917246. N Engl J Med. 2020. PMID: 32757523 Clinical Trial.
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.
[Introduction. Multiple sclerosis].
Antigüedad AR. Antigüedad AR. Med Clin (Barc). 2014 Dec;143 Suppl 3:1-2. doi: 10.1016/S0025-7753(15)30001-4. Med Clin (Barc). 2014. PMID: 25732941 Spanish. No abstract available.
[Biomarkers in multiple sclerosis].
Fernández Ó, Arroyo-González R, Rodríguez-Antigüedad A, García-Merino JA, Comabella M, Villar LM, Izquierdo G, Tintoré M, Oreja-Guevara C, Álvarez-Cermeño JC, Meca-Lallana JE, Prieto JM, Ramió-Torrentà L, Martínez-Yélamos S, Montalban X. Fernández Ó, et al. Among authors: rodriguez antiguedad a. Rev Neurol. 2013 Apr 1;56(7):375-90. Rev Neurol. 2013. PMID: 23520007 Free article. Review. Spanish.
Biomarkers in multiple sclerosis: an update for 2014.
Fernandez O, Martin R, Rovira A, Llufriu S, Vidal-Jordana A, Fernandez-Sanchez VE, Alvarez-Cermeno JC, Izquierdo G, Arroyo-Gonzalez R, Rodriguez-Antiguedad A, Casanova-Estruch B, Montalban X. Fernandez O, et al. Among authors: rodriguez antiguedad a. Rev Neurol. 2014 Jun 16;58(12):553-70. Rev Neurol. 2014. PMID: 24915032 Free article. Review. English, Spanish.
Excitotoxic damage to white matter.
Matute C, Alberdi E, Domercq M, Sánchez-Gómez MV, Pérez-Samartín A, Rodríguez-Antigüedad A, Pérez-Cerdá F. Matute C, et al. Among authors: rodriguez antiguedad a. J Anat. 2007 Jun;210(6):693-702. doi: 10.1111/j.1469-7580.2007.00733.x. Epub 2007 May 15. J Anat. 2007. PMID: 17504270 Free PMC article. Review.
38 results